Edwards Lifesciences Corp. (EW) Tops Q2 EPS by 6c, Q3 EPS Light
Edwards Lifesciences Corp. (NYSE: EW) reported Q2 EPS of $0.82, $0.06 better than the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
